The seed keyword extracted from the input is “medical system”. The term refers not only to hospitals, clinics, and insurers but also to the incentives, workflows, and clinical policies that shape how patients experience diagnosis, treatment, monitoring, and follow-up. In educational medicine, it is important to distinguish the legitimate goals of health systems—reducing morbidity and mortality, improving access, and ensuring safety—from unintended consequences that can create persistent illness burdens or patient dependence on continuous care.
A core concept is that clinical decisions operate within organizational constraints: limited time, standardized pathways, reimbursement structures, documentation requirements, medicolegal risk management, and supply availability. These factors can influence prescribing patterns, referral timing, and the intensity of follow-up. When the system prioritizes throughput, risk avoidance, or predictable utilization, clinicians may default to interventions that require ongoing monitoring rather than definitive resolution. This does not imply that individuals are acting maliciously; instead, it reflects how care pathways can produce iatrogenic effects—harm caused by medical care, including adverse drug reactions, unnecessary procedures, and harm from fragmentation of services.
One mechanism by which a medical system can contribute to chronicity is “therapeutic inertia” paired with “cycle of follow-up.” Therapeutic inertia is failure to adjust treatment plans when goals are not being met. In chronic conditions such as diabetes, hypertension, chronic pain, and some mental health disorders, delayed optimization can lead to progressive symptoms, increased disability, and greater reliance on repeated visits. Another mechanism is “fragmentation” across specialties: when care is split among disconnected teams, clinicians may address symptoms rather than underlying causes, increasing the likelihood of redundant testing and polypharmacy.
A second mechanism involves incentive-driven utilization. Health economics describes how payment models can shape behavior. Fee-for-service arrangements tend to increase volume of services, while capitated models may incentivize cost control. In practice, mixed incentives may coexist, and they can influence the frequency of visits, imaging, referrals, and long-term medication use. When ongoing monitoring is clinically justified, it is beneficial. However, if monitoring continues after stabilization without reassessment of goals, it can reinforce a patient’s perception of incurability and increase anxiety about relapse.
A third mechanism is psychological reinforcement and the development of medicalized identity. Repeated labeling of symptoms, extensive diagnostic workups, and frequent follow-ups can create a learned pattern: symptom vigilance, catastrophic interpretation, and reliance on clinicians to validate safety. In behavioral medicine, this resembles reinforcement learning, where repeated reassurance and interventions temporarily reduce distress, leading to further help-seeking when discomfort recurs. Over time, patients may interpret normal bodily sensations as threats, which can worsen outcomes in functional disorders, somatic symptom disorders, and some anxiety-spectrum conditions.
Importantly, health systems also provide many effective therapies. Evidence-based care can prevent complications, reduce symptom severity, and improve survival. For example, guideline-directed management of cardiovascular disease demonstrably reduces events, vaccination programs prevent infectious disease burden, and structured psychotherapy for anxiety and depression improves functioning. Therefore, the medical question is not whether modern systems can help, but how to design and deliver care that maximizes benefit and minimizes dependency.
Clinically, several strategies reduce iatrogenesis and reinforce recovery. First, use shared decision-making and clear treatment endpoints: patients should know what success looks like, when reassessment occurs, and when tapering or de-escalation is appropriate. Second, apply stepped-care models in chronic and mental health conditions, escalating only when needed and de-escalating when stable. Third, integrate multidisciplinary care with care coordination to address root contributors such as medication side effects, sleep disorders, substance use, psychosocial stressors, and lifestyle factors. Fourth, implement deprescribing protocols for medications where harms outweigh benefits, particularly in polypharmacy and older adults.
From a public health perspective, improving outcomes also requires transparency in outcomes measurement and reducing administrative friction that limits patient-centered time. Systems should support clinicians with clinical decision support, evidence summaries, and workflow redesign so that care is both safe and efficient. Patient education should be framed around prognosis and function, not endless escalation, emphasizing recovery, self-management skills, and when to seek urgent care.
Finally, the ethical aim is autonomy and well-being rather than perpetual utilization. A mature healthcare system seeks to minimize unnecessary interventions, respect patient preferences, and support sustainable health behaviors. When patients experience ongoing symptoms, the response should be iterative, compassionate reassessment—not reflexive continuation of the same pathway.
Source: [Creator/Source]
Kenny Carmody: The Rockefeller medical system wasn’t built to heal you. It was built in 1911 (Flexner Report) to manage you. Cure = lost customer. Sick forever = infinite revenue. They buried energy. They buried biology. They built a subscription model out of your suffering. The business. #breaking
— @KennyCarmody May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
